The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo
Open accessAbstract
Insulin signalling and nutrient levels coordinate the metabolic response to feeding in the liver. Insulin signals in hepatocytes to activate Akt, which inhibits Foxo1 suppressing hepatic glucose production (HGP) and allowing the transition to the postprandial state. Here we provide genetic evidence that insulin regulates HGP by both direct and indirect hepatic mechanisms. Liver-specific ablation of the IR (L-Insulin Receptor KO) induces glucose intolerance, insulin resistance and prevents the appropriate transcriptional response to feeding. Liver-specific deletion of Foxo1 (L-IRFoxo1DKO) rescues glucose tolerance and allows for normal suppression of HGP and gluconeogenic gene expression in response to insulin, despite lack of autonomous liver insulin signalling. These data indicate that in the absence of Foxo1, insulin signals via an intermediary extrahepatic tissue to regulate liver glucose production. Importantly, a hepatic mechanism distinct from the IR–Akt–Foxo1 axis exists to regulate glucose production. Insulin and the transcription factor FoxO1 are key regulators of hepatic glucose metabolism. Here, Titchenell et al. provide evidence for the existence of an insulin-dependent extrahepatic pathway that is fully capable of regulating hepatic glucose production in the absence of hepatic FoxO1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intact hepatic insulin signaling is, however, dispensable for the postprandial repression of hepatic glucose production in the absence of hepatic FoxO1 32, 33, highlighting the importance of hypothalamic insulin signaling in the control of liver glucose metabolism 34.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487
Michael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296
Brüning, J. C., Michael, M. D., Winnay, J. N., Hayashi, T., Hörsch, D., Accili, D., Goodyear, L. J., & Kahn, C. R. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80155-0 · Cited by 1,173
The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism
Koo, S., Flechner, L., Qi, L., Zhang, X., Screaton, R. A., Jeffries, S., Hedrick, S. A., Xu, W., Boussouar, F., Brindle, P. K., et al. (2005) · Nature · doi:10.1038/nature03967 · Cited by 1,026
Menon, S., Dibble, C. C., Talbott, G., Hoxhaj, G., Valvezan, A. J., Takahashi, H., Cantley, L. C., & Manning, B. D. (2014) · Cell · doi:10.1016/j.cell.2013.11.049 · Cited by 766
Li, S., Brown, M. S., & Goldstein, J. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914798107 · Cited by 733
Insulin Action in AgRP-Expressing Neurons Is Required for Suppression of Hepatic Glucose Production
Könner, A. C., Janoschek, R., Plum, L., Jordan, S. D., Rother, E., Ma, X., Xu, C., Enriori, P., Hampel, B., Barsh, G. S., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.004 · Cited by 695
Yecies, J. L., Zhang, H., Menon, S., Liu, S., Yecies, D. W., Lipovsky, A. I., Görgün, C. Z., Kwiatkowski, D. J., Hotamışlıgil, G. S., Lee, C., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.06.002 · Cited by 685
Matsumoto, M., Pocai, A., Rossetti, L., DePinho, R. A., & Accili, D. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.08.006 · Cited by 624
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–168 of 168
Lysophosphatidic acid counteracts glucagon-induced hepatocyte glucose production via STAT3
Taddeo, E. P., Hargett, S. R., Lahiri, S., Nelson, M. E., Liao, J. A., Li, C., Slack‐Davis, J. K., Tomsig, J. L., Lynch, K. R., Yan, Z., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00210-y · Cited by 15
Insulin‐Mediated PI3K and AKT Signaling
Kwon, H., & Pessin, J. E. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch39 · Cited by 14
Bioactive lipids and metabolic syndrome—a symposium report
DeVito, L. M., Dennis, E. A., Kahn, B. B., Shulman, G. I., Witztum, J. L., Sadhu, S., Nickels, J. T., Spite, M. R., Smyth, S. S., & Spiegel, S. (2022) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14752 · Cited by 12
Brierley, G. V., Webber, H., Rasijeff, E., Grocott, S., Siddle, K., & Semple, R. K. (2020) · Diabetes · doi:10.2337/db20-0345 · Cited by 13
Liu, D., Zhao, L., Wang, Y., Wang, L., Wu, D., & Liu, Y. (2025) · Pharmaceuticals · doi:10.3390/ph18121890 · Cited by 12
Effects of the Activation of Three Major Hepatic Akt Substrates on Glucose Metabolism in Male Mice
Sakai, G., Inoue, I., Suzuki, T., Sumita, T., Inukai, K., Katayama, S., Awata, T., Yamada, T., Asano, T., Katagiri, H., et al. (2017) · Endocrinology · doi:10.1210/en.2016-1969 · Cited by 13
Ouaamari, A. E., O‐Sullivan, I., Shirakawa, J., Basile, G., Zhang, W., Roger, S., Thomou, T., Xu, S., Qiang, G., Liew, C. W., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006031 · Cited by 11
Insulin Resistance in Type 2 Diabetes
Roden, M., Petersen, K. F., & Shulman, G. I. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch17 · Cited by 14
Mechanisms and Linkage of Insulin Signaling, Resistance, and Inflammation
Hadid, K. A., Alassaf, F. A., & Abed, M. N. (2023) · Al-Mağallaẗ al-ʻirāqiyyaẗ li-l-ṣaydalaẗ · doi:10.33899/iphr.2023.144181.1065 · Cited by 11
Jeddi, S., Gheibi, S., Carlström, M., Kashfi, K., & Ghasemi, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118770 · Cited by 11
Nutrient and hormone-sensing-dependent regulation
Lam, T. K. T. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.204 · Cited by 11
Shin, M., Han, W., Joo, H., Bevans‐Fonti, S., Shiota, M., Stefanovski, D., & Polotsky, V. Y. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00975.2016 · Cited by 11
Neto, C. J. C. L., de Melo, I. M. F., Alpiovezza, P. K. B. D. M., de Albuquerque, Y. M. L., Soares, A. F., Teixeira, Á. A. C., & Teixeira, V. W. (2023) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2023.114357 · Cited by 11
Hepatic sialic acid synthesis modulates glucose homeostasis in both liver and skeletal muscle
Peng, J., Yu, L., Huang, L., Paschoal, V. A., Chu, H., de Souza, C. O., Varre, J. V., Oh, D. Y., Kohler, J. J., Xiao, X., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101812 · Cited by 10
Forkhead Box O (FoxO) Transcription Factors in Autophagy, Metabolic Health, and Tissue Homeostasis
Liu, L., & Cheng, Z. (2018) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-98146-8_4 · Cited by 11
Bian, H., Ma, J., Qu, S., Qian, J., Hao, C., Liu, C., & Gao, X. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-10013-6 · Cited by 9
Rodríguez, R., Lee, A. Y., Godoy-Lugo, J. A., Martinez, B., Ohsaki, H., Nakano, D., Parkes, D. G., Nishiyama, A., Vázquez‐Medina, J. P., & Ortiz, R. M. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00584.2020 · Cited by 9
Pfeifer, M. A., Liebmann, M., Beuerle, T., Grupe, K., & Scherneck, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126434 · Cited by 9
Song, J., Duivenvoorde, L. P. M., Grefte, S., Kuda, O., Martínez-Ramírez, F., van der Stelt, I., Mastorakou, D., van Schothorst, E. M., & Keijer, J. (2023) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-023-02854-4 · Cited by 9
Analysis of Insulin Resistance in Nonalcoholic Steatohepatitis
Kim, H., Zhang, D., Song, Z., Tong, X., & Zhang, K. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2128-8_18 · Cited by 8
Wang, S., Shi, Y., Xin, R., Kang, H., Xiong, H., & Ren, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1614006 · Cited by 12
Sostre‐Colón, J., Gavin, M. J., Santoleri, D., & Titchenell, P. M. (2022) · Endocrinology · doi:10.1210/endocr/bqac035 · Cited by 7
Self-citationZheng, Q., Wang, Y., Chen, G., & Mao, X. (2025) · Food Research International · doi:10.1016/j.foodres.2025.116471 · Cited by 7
White, M. F. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch8 · Cited by 8
Non‐alcoholic Fatty Liver Disease and Insulin Resistance
Petersen, M. C., Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch37 · Cited by 10
Lu, C., Zhang, Y., Sun, C., Na, Y., Sun, H., Ma, J., Wang, X., & Cang, X. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70352 · Cited by 6
Santoleri, D., Lim, H., Emmett, M. J., Stoute, J., Gavin, M. J., Sostre‐Colón, J., Uehara, K., Welles, J. E., Liu, K. F., Lazar, M. A., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104410 · Cited by 5
Self-citationZhang, T., Zhang, Y., Tao, J., Rong, X., & Yang, Y. (2023) · Endocrine · doi:10.1007/s12020-023-03559-5 · Cited by 5
Gao, H., Bianba, Z., Mo, X., Hu, W., Feng, Z., Zhou, F., & Zhang, T. (2024) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed9080175 · Cited by 5
Sleep disorders in hepatocellular carcinoma
Qian, J., Ruan, M., Wang, Z., Dong, W., Jia, J.-H., Feng, X.-C., & Liu, H. (2025) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v17.i10.110503 · Cited by 5
Abo-khookh, A. M., Ghoneim, H. A., Abdelaziz, R. R., Nader, M. A., & Shawky, N. M. (2023) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgad012 · Cited by 5
Joseph, A., Parvathy, S., Varma, K. K., & Nandakumar, A. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00694-y · Cited by 5
Cheng, F., Yun, S., Cao, J., Chang, M., Meng, J., Liu, J., Cheng, Y., & Feng, C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.700049 · Cited by 5
Yuenyong, I., Potue, P., Maneesai, P., Khamseekaew, J., Manimmanakorn, A., Iampanichakul, M., & Pakdeechote, P. (2025) · Life · doi:10.3390/life15030491 · Cited by 4
Duangjan, C., Arpawong, T. E., Spatola, B. N., & Curran, S. P. (2024) · GeroScience · doi:10.1007/s11357-024-01196-y · Cited by 4
Roden, M. (2016) · Diabetologia · doi:10.1007/s00125-016-3911-x · Cited by 3
Potential role of microRNAs in selective hepatic insulin resistance: From paradox to the paradigm
Palihaderu, P. A. D. S., Mendis, B. I. L. M., Premarathne, J. M. K. J. K., Dias, W. K. R. R., Yeap, S. K., Ho, W. Y., Dissanayake, A. S., Rajapakse, I. H., Karunanayake, P., Senarath, U., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1028846 · Cited by 3
Role of serum- and glucocorticoid-inducible kinase 1 in the regulation of hepatic gluconeogenesis
Xu, Z., Wang, Y., Liu, Q., Wang, S., Sheng, C., Chen, J., Tan, J., Wang, X., Shao, L., & Zhou, L. (2023) · Journal of Molecular Endocrinology · doi:10.1530/jme-23-0046 · Cited by 4
Rewiring tumor metabolism: heterogeneity, oncometabolites, and adaptive plasticity
Yang, J., Zhou, C. C., Kumar, S. V., Shay, C., & Teng, Y. (2026) · Experimental Hematology and Oncology · doi:10.1186/s40164-026-00795-z · Cited by 2
Wong, C., Lim, Y. M., Liew, K. B., Chew, Y.-L., Chua, A.-L., & Lee, S.-K. (2025) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2025.05.005 · Cited by 5
He, Q.-Y., Peng, J., Yu, R.-X., Luo, T., Li, Y.-H., Zhong, Z.-R., Qin, Z., Wang, F., Li, J., & Luo, S. (2025) · Marine Biotechnology · doi:10.1007/s10126-025-10513-1 · Cited by 2
IPMK modulates insulin-mediated suppression of hepatic glucose productionPreprint
Jung, I., Anokye‐Danso, F., Jin, S., Ahima, R. S., & Kim, S. F. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.10.483655 · Cited by 2
White, M. F. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch9 · Cited by 2
Wang, M., Yao, M., Yue, H., Tian, Y., Zhao, Z., Xue, C., Zhang, T., & Wang, Y. (2025) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250417 · Cited by 1
Kalafut, K. C., Cormerais, Y., Cissé, M. Y., Lapp, S. C., Inouye, K., Hotamışlıgil, G. S., & Manning, B. D. (2026) · Nature Communications · doi:10.1038/s41467-026-77216-6 · Cited by 2
BRD7 improves glucose homeostasis independent of IRS proteins
Kim, Y., Lee, J. M., Han, Y., Tao, R., White, M. F., Liu, R., & Park, S. W. (2023) · Journal of Endocrinology · doi:10.1530/joe-23-0119 · Cited by 1
Hepatic WDR23 proteostasis mediates insulin clearance by regulating insulin-degrading enzymePreprint
Duangjan, C., Arpawong, T. E., Spatola, B. N., & Curran, S. P. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.24.516014 · Cited by 1
Molecular and physiological regulation of adiponectin exocytosis in white adipocytes
Komai, A. M. (2015) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Mechanisms of hepatic glucose production revealed
Greenhill, C. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.77
Wilson, C. G., Mattis, A. N., Tran, J. L., Corbit, K. C., & Weiss, E. J. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/079236
Regulation of Metabolism by Hepatic OXPHOS: A Dissertation
Akie, T. E. (2015) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2388v
Novel Mediators of Diabetes-Associated Cardiovascular Disease
Gearing, M. E. (2017) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
iPSCs in insulin resistance, type 2 diabetes, and the metabolic syndrome
Carcamo‐Orive, I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99892-5.00020-7
Ekspresi Protein FoxO1 dan Gen Glukosa 6 Fosfatase pada Tikus dengan Diet Restriksi Vitamin B12
Sianipar, I. R., Andraini, T., Santoso, . I. S., Ujianti, I., & Antoni, M. (2022) · Jurnal Kedokteran Meditek · doi:10.36452/jkdoktmeditek.v28i2.2351
Faculty Opinions recommendation of Regulation of hepatic glucose metabolism in health and disease.
Aguilar-Salinas, C. A. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727825142.793558322
Likitnukul, S., Thammacharoen, S., Sriwatananukulkit, O., Duangtha, C., Hemstapat, R., Saengsawang, W., Mangmool, S., & Pinthong, D. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4115224
Kang, S., Song, M., & Kang, H. (2025) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2025.02.005
Léandre, F., Iddir, A., Godard, C., Lagoutte, I., Caldiero, A., Souid, S., Pinto, S., Augustin, J., Malham, V. B., Alves, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.02.655477
Varunteja, B., Gupta, N., Kumari, A., Mukherjee, T., Mohanty, S., Nayak, N., Chopra, M. P., & Pattnaik, A. K. (2025) · Current Drug Metabolism · doi:10.2174/0113892002393234250908070423
Metabolic Factors Affecting Liver Regeneration
Ammann, M., & Starlinger, P. P. (2026) · Springer eBooks · doi:10.1007/978-3-032-10997-2_3
Ponnusamy, R., Giriraj, K., Dharani, S., & Sowndhararajan, K. (2026) · Springer eBooks · doi:10.1007/978-3-032-17170-2_13
Homéostasie des céramides et hépatopathies métaboliques
Régnier, M. (2018) · theses.fr (ABES) · doi:10.70675/2fb92711z373cz4b27z8082z7aa3f8930e63
Influence du sexe dans la susceptibilité aux hépatopathies métaboliques
Smati, S. (2019) · theses.fr (ABES) · doi:10.70675/01997f55za990z41e6z96baz8221de2a6281
Rôle de l'isoforme A du récepteur de l'insuline dans l'homéostasie et la carcinogenèse hépatiques
Léandre, F. (2024) · theses.fr (ABES) · doi:10.70675/df1bc445z5d98z462dzbc59za0d4015bcf04
Reduction in Hepatic Phosphatidylcholine Biosynthesis Promotes MASH Through Copper DeficiencyPreprint
Welles, J. E., Garifallou, J. P., Gonzalez, M. V., Santoleri, D., Choudhury, F. K., DeNicola, G. M., Martin, R. W., Jiang, C., Kim, J., Li, G., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.13.723926
Self-citation
Metadata
- Authors
- Titchenell, P. M., Chu, Q., Monks, B. R., & Birnbaum, M. J.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Birnbaum, Morris J.
- Venue
- Nature Communications
- Published
- 2015-05-12
- Volume
- 6
- Issue
- 1
- Pages
- 7078-7078
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4429930
- OpenAlex
- W240175869
- Cited by
- 169
- References
- 43
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 11 · 2023: 14 · 2022: 18 · 2021: 15 · 2020: 15 · 2019: 11 · 2018: 19 · 2017: 24 · 2016: 14 · 2015: 8
- FWCI
- 9.41
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nature Communications (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK056886, F32DK101175)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- hepatic glucose production, FOXO1, insulin receptor, Akt, gluconeogenesis, impaired glucose tolerance, insulin resistance, liver-specific knockout, postprandial glucose metabolism, hepatic glucose metabolism
- MeSH terms
- Forkhead Box Protein O1, Animals, Gene Expression Regulation, Gluconeogenesis, Glucose, Glucose Tolerance Test, Insulin Resistance, Liver, Male, Receptor, Insulin, RNA, Messenger, Signal Transduction, Mice, Knockout, Mice, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review